m7G(5')ppp(5')(2'-OMeA)p(2'-OEtA)pG, 100 mM sodium salt solution
m7G(5')ppp(5')(2'-OMeA)p(2'-OEtA)pG, 100 mM sodium salt solution - N (Normal) is backordered and will ship as soon as it is back in stock.
Couldn't load pickup availability
Shipping notes
Shipping notes
Related Products
Specifications
Specifications
-
Catalog No.ON-582
-
SMILES[O-]P(OC[C@H]1O[C@@H](N2C(N=CN=C3N)=C3N=C2)[C@H](OC)[C@@H]1OP(OC[C@H]4O[C@@H](N(C=N5)C6=C5C(N)=NC=N6)[C@H](OCC)[C@@H]4OP(OC[C@H]7O[C@@H](N(C=N8)C9=C8C(NC(N)=N9)=O)[C@H](O)[C@@H]7O)([O-])=O)([O-])=O)(OP(OP(OC[C@H]%10O[C@@H](N(C=[N+]%11C)C%12=C%11C(NC(N)=N%12)=O)[C@H](O)[C@@H]%10O)([O-])=O)([O-])=O)=O.[xNa+]
-
Molecular FormulaC44H59N20O30P5 (free acid)
-
Molecular Weight1502.93 (free acid)
-
AppearanceClear and colorless to slightly yellow solution, free from visible foreign matter
-
PurityHPLC≥95%
-
Storage Condition-20±5℃
Documentation
Documentation
-
Catalog No.ON-582
-
SMILES[O-]P(OC[C@H]1O[C@@H](N2C(N=CN=C3N)=C3N=C2)[C@H](OC)[C@@H]1OP(OC[C@H]4O[C@@H](N(C=N5)C6=C5C(N)=NC=N6)[C@H](OCC)[C@@H]4OP(OC[C@H]7O[C@@H](N(C=N8)C9=C8C(NC(N)=N9)=O)[C@H](O)[C@@H]7O)([O-])=O)([O-])=O)(OP(OP(OC[C@H]%10O[C@@H](N(C=[N+]%11C)C%12=C%11C(NC(N)=N%12)=O)[C@H](O)[C@@H]%10O)([O-])=O)([O-])=O)=O.[xNa+]
-
Molecular FormulaC44H59N20O30P5 (free acid)
-
Molecular Weight1502.93 (free acid)
-
AppearanceClear and colorless to slightly yellow solution, free from visible foreign matter
-
PurityHPLC≥95%
-
Storage Condition-20±5℃
Why choose Hongene?
Trusted Partner in Nucleic Acid
Integrated Supply & Commercial Scale
With 26+ years of expertise, we control a secure supply chain for RNA raw materials and provide reliable GMP-grade oligo synthesis from research to commercial kilogram-scale production.
Proprietary Technology & IP
Our proprietary Chemoenzymatic Ligation Platform combines chemical andenzymatic methods, enabling high-putity, cost-effective, and large-scale production of RNA-based therapeutics.
Rigorous Quality
We implement multiple stringent QC steps, maintain ISO certifications, and ensure >99% batch-to-batch consistency, reducing scale-up and PPQ risks.
Manufacturing Scalability
Hongene operates 1.67 million sq. ft Oligonucleotide Manufacturing Facility, with advanced equipments including multiple OligoPilot™ and OligoProcess™ synthesizers (10-1800 mmol). 48 flexible production lines enable one-stop seamless scaling-up of API production from gram-level to tons and acheive high purity of 98%, meeting NMPA, FDA, and EMA standards.
Global Business Network
Our products and services reach over 40 countries and regions, supporting around 3,000 clients worldwide.
